​

Carisma Therapeutics Ownership | Who Owns Carisma Therapeutics?

OverviewForecastFinancialsChart

Carisma Therapeutics Ownership Summary

Carisma Therapeutics is owned by 23.04% insiders, and 76.96% retail investors.

CARM Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCarisma Therapeutics-23.04%76.96%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryBiotech Stocks 379.61%11.70%-291.31%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20261-66.67%785-99.95%-0.01%--100.00%--
Mar 31, 20263-57.14%1,474,225-5.80%325.15%1-66.67%--
Dec 31, 20255-83.87%51,694-98.32%-0.23%2-60.00%--100.00%
Sep 30, 202530-6.25%3,075,840-22.45%78.16%5-44.44%4-20.00%
Jun 30, 202534-2.86%3,982,439-2.93%99.78%10-28.57%6-

Recent Insider Transactions

DateNameRoleActivityValue
Oct 07, 2025Klichinsky Michael Chief Scientific OfficerSell$14.48K
Oct 01, 2025Klichinsky Michael Chief Scientific OfficerSell$42.41K
Oct 02, 2025Klichinsky Michael Chief Scientific OfficerSell$50.86K
Oct 03, 2025Klichinsky Michael Chief Scientific OfficerSell$31.08K

Insider Transactions Trends

DateBuySell
2025 Q4-4
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--

CARM Ownership FAQ

Who Owns Carisma Therapeutics?

Carisma Therapeutics shareholders are primarily institutional investors at 0.00%, followed by 23.04% insiders and 76.96% retail investors. The average institutional ownership in Carisma Therapeutics's industry, Biotech Stocks , is 379.61%, which Carisma Therapeutics falls below.

Does Blackrock own Carisma Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Carisma Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools